Qilong Yi

14.4k citations

204 papers · 10.7k indexed · 3 hit papers · h-index 54

Impact in

Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
Hepatology top 0.5%
- Hepatitis C virus research

Papers in

Management of Technology and Innovation 33
- Blood donation and transfusion practices 33
Biochemistry 23
- Blood transfusion and management 20

Co-authors: Salim Yusuf Eva Lonn Murray Krahn Hla‐Hla Thein Gregory J. Dore John W. Eikelboom Jackie Bosch Hertzel C. Gerstein
Journals: Transfusion (46 papers)Vox Sanguinis (11 papers)Stroke (7 papers)Circulation (7 papers)Microbiology Spectrum (7 papers)
Partner nations: Canada United States Australia

In The Last Decade

Qilong Yi

200 papers receiving 10.3k citations

Hit Papers

align trajectories log scale

Estimation of stage‐specific fibrosis progression rates in chronic hepatitis C virus infection 2008 · 635 citations

Peers

Countries citing papers authored by Qilong Yi

Since Specialization

Citations

This map shows the geographic impact of Qilong Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qilong Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qilong Yi more than expected).

Fields of papers citing papers by Qilong Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qilong Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qilong Yi. The network helps show where Qilong Yi may publish in the future.

Co-authors

The 25 scholars most cited alongside Qilong Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Qilong Yi Line = papers co-authored together Qilong Yi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	From Light to Cure: Precision Phototherapies for Antibiotic‐Refractory Biofilm Infections Angewandte Chemie International Edition ·Qihang Ding, Yuxin Xie, Kexin Xiong, Hong Jia, Lin Chen, Chunbin Li, Qilong Yi, Pengfei Zhang, Ling Mei, Ben Zhong Tang	2025	0
2	Red cell concentrates from teen male donors contain poor‐quality biologically older cells Vox Sanguinis ·Olga Mykhailova, Mackenzie Brandon‐Coatham, C.T. Phan, Mahsa Yazdanbakhsh, Carly Olafson, Qilong Yi, Tamir Kanias, Jason P. Acker	2024	7
3	Estimated median density identifies donor age and sex differences in red blood cell biological age Transfusion ·Olga Mykhailova, Mackenzie Brandon‐Coatham, Kiarra Durand, Carly Olafson, April Xu, Qilong Yi, Tamir Kanias, Jason P. Acker	2024	7
4	Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic Approaches Canadian Journal of Cardiology ·John W. Eikelboom, Qilong Yi, William F. McIntyre, Jackie Bosch, Richard Whitlock, Stuart J. Connolly, Thomas Scheier, Eva Muehlhofer, Ákos F. Pap, Stuart Pocock, Shrikant I. Bangdiwala	2024	2
5	Impact of input volume on red cell quality in deglycerolized RBCs using a modified ACP‐215 protocol Transfusion ·Anita Howell, Angela Hill, Wanda Lefresne, B. R. Dennis, Tracey R. Turner, Qilong Yi, Carly Olafson, Nishaka William, Jason P. Acker	2024	1
6	Measurement of lead, mercury, and cadmium in blood donors in Canada Transfusion ·Narges Hadjesfandiari, Katherine Serrano, Tomas Richardson‐Sanchez, Vilte Barakauskas, Qilong Yi, Michael Murphy, Dana V. Devine	2024	1
7	Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021 Microbiology Spectrum ·Yi-Chan Lin, David H. Evans, Ninette F Robbins, Guillermo Orjuela, Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne‐Claude Gingras, Ashleigh R. Tuite, Qilong Yi, Sheila F. O’Brien, Steven J. Drews	2023	0
8	Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation European Heart Journal ·Alexander P. Benz, Stefan H. Hohnloser, John W. Eikelboom, Anthony Carnicelli, Robert P. Giugliano, Christopher B. Granger, Josephine Harrington, Ziad Hijazi, David A. Morrow, Manesh R. Patel, David Seiffge, Ashkan Shoamanesh, Lars Wallentin, Qilong Yi, Stuart J. Connolly	2023	23
9	Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses Microbiology Spectrum ·Yi-Chan Lin, David H. Evans, Ninette F. Robbins, Guillermo Orjuela, Queenie Hu, Reuben Samson, Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne‐Claude Gingras, Ashleigh R. Tuite, Qilong Yi, Sheila F. O’Brien, Steven J. Drews	2022	7
10	The chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia Blood Advances ·Donald R. Branch, Regina M. Leger, Darinka Sakac, Qilong Yi, Trang T. Duong, Rae S. M. Yeung, Beth Binnington, Evgenia M. Bloch	2022	5
11	Repeated Measures of Modified Rankin Scale Scores to Assess Functional Recovery From Stroke: AFFINITY Study Findings Journal of the American Heart Association ·Alexander Chye, Maree L. Hackett, Graeme J. Hankey, Erik Lundström, Osvaldo P. Almeida, John Gommans, Martin Dennis, Stephen Jan, Gillian Mead, Andrew H. Ford, Christopher Etherton‐Beer, Leon Flicker, Candice Delcourt, Laurent Billot, Craig S. Anderson, Katharina S. Sunnerhagen, Qilong Yi, Séverine Bompoint, Thang Huy Nguyen, Thomas Lung	2022	14
12	Closed system processing variables affect post‐thaw quality characteristics of cryopreserved red cell concentrates Transfusion ·Anita Howell, Tracey R. Turner, Adele Hansen, Larissa Lautner, Qilong Yi, Jason P. Acker	2022	6
13	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard PLoS ONE ·Sahar Saeed, Sheila F. O’Brien, Kento T. Abe, Qilong Yi, Bhavisha Rathod, Jenny Wang, Mahya Fazel‐Zarandi, Ashleigh R. Tuite, David N. Fisman, Heidi Wood, Karen Colwill, Anne‐Claude Gingras, Steven J. Drews	2021	12
14	SARS‐CoV‐2 seroprevalence among blood donors after the first COVID‐19 wave in Canada Transfusion ·Sahar Saeed, Steven J. Drews, Chantale Pambrun, Qilong Yi, Lori Osmond, Sheila F. O’Brien	2021	35
15	Long‐term morbidity and mortality in a Canadian post‐transfusion hepatitis C cohort: Over 15 years of follow‐up Journal of Viral Hepatitis ·Yeva Sahakyan, William Wong, Qilong Yi, Hla‐Hla Thein, George Tomlinson, Murray Krahn	2019	4
16	Human T‐cell lymphotropic virus: A simulation model to estimate residual risk with universal leucoreduction and testing strategies in Canada Vox Sanguinis ·Sheila F. O’Brien, Qilong Yi, Mindy Goldman, Yves Grégoire, Gilles Delage	2018	6
17	Timing of gamma irradiation and blood donor sex influences in vitro characteristics of red blood cells Transfusion ·Dirk de Korte, Louis Thibault, Wiebke Handke, Sarah K. Harm, Alex Morrison, Áine Fitzpatrick, Denese C. Marks, Qilong Yi, Jason P. Acker, (unknown)	2018	20
18	Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm‐derived Staphylococcus epidermidis in buffy coat platelet concentrates Vox Sanguinis ·Mariam Taha, Brankica Culibrk, M. Kaláb, Peter Schubert, Qilong Yi, Raymond P. Goodrich, Sandra Ramírez‐Arcos	2017	14
19	Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre‐ and postwash storage times and conditions Transfusion ·Adele Hansen, Qilong Yi, Jason P. Acker	2013	35
20	Thromboprophylaxis practice patterns in two Western Australian teaching hospitals. PubMed ·John W. Eikelboom, Anita Mazzarol, Daniel J. Quinlan, R.J. Beaver, James M. Williamson, Qilong Yi, Graeme J. Hankey	2004	21

About Qilong Yi

Qilong Yi is a scholar working on Management of Technology and Innovation, Biochemistry, Hematology, Internal Medicine and Hepatology, having authored 204 papers that have together received 10.7k indexed citations. Recurring topics across this work include Blood donation and transfusion practices (33 papers), Blood transfusion and management (20 papers), Hepatitis C virus research (18 papers), Blood Pressure and Hypertension Studies (14 papers), COVID-19 Clinical Research Studies (13 papers), Blood groups and transfusion (13 papers), Hepatitis B Virus Studies (13 papers) and Liver Disease Diagnosis and Treatment (12 papers). The work is most often cited by research in Internal Medicine (674 citations), Hepatology (1.2k citations), Cardiology and Cardiovascular Medicine (3.1k citations), Hematology (1.2k citations) and Biochemistry (616 citations). Qilong Yi has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Salim Yusuf, Eva Lonn, Murray Krahn, Hla‐Hla Thein, Gregory J. Dore, John W. Eikelboom, Jackie Bosch, Hertzel C. Gerstein, Jack Hirsh and Marilyn Johnston. Their work appears in journals such as Transfusion, Vox Sanguinis, Stroke, Circulation and Microbiology Spectrum.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact